Skip to main content
Log in

Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases

  • Case Report
  • Published:
Breast Cancer Aims and scope Submit manuscript

Abstract

We report 7 rare cases of recurrent breast cancers who presented with central nervous system (CNS) metastases as the initial relapse site without any other organ metastases. The average age of the patients at surgery was 42.6 years old of age (median 45: range 32-60), and 6 of the 7 cases (86%) were premenopausal. The mean disease-free period was 25.7 months (median 22, range 2-60 months). The primary tumors were all invasive ductal carcinomas. The estrogen receptor and progesterone receptor status of the 3 tumors available for study were all negative. The metastatic CNS lesions included the cerebrum (4 cases), cerebellum, cervical spinal cord, and meninges. In 6 out of these 7 cases (86%), the CNS metastasis was the initial recurrent lesion. Multidisciplinary treatments including surgery, radiotherapy and systemic or intrathecal chemotherapy were given. Although the mean survival time from clinical manifestations of the metastases of the 4 deceased patients was 20 months (median 20.5; range 6-33), one patient treated with surgery and radiotherapy is been still alivel 8 years later. These cases were also notable for the fact that the only metastatic site was in the CNS only during the entire clinical course, except for 2 cases, one with ocular adnexa metastasis, and the other with cervical lymph node metastasis. Premenopausal patients with negative hormone receptor status are more likely to develop this type of recurrence, regardless of the histological type. It is necessary to pay attention to neurological symptoms and signs during follow-up of breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CNS:

Central nervous system

ER:

Estrogen receptor

PgR:

Progesterone receptor

CPA:

Cyclophosphamide

ADM:

Adriamycin

MTX:

Methotrexate

5FU:

5-fluorouracil

TAM:

Tamoxifen

CT:

Computed tomography

MRI:

Magnetic resonance imaging

References

  1. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy.Cancer 41:1170–1178, 1978.

    Article  PubMed  CAS  Google Scholar 

  2. Glass JP, Foley KM: Brain metastases in patients with breast cancer. In: Harris JR, Lippman ME,et al eds, Diseases of the Breast, Lippincott-Raven Publishers, Philadelphia, pp769–779, 1996.

    Google Scholar 

  3. Jayson GC, Howell A, Harris M,et al: Carcinomatous meningitis in patients with breast cancer.Cancer 74:3135–3141, 1994.

    Article  PubMed  CAS  Google Scholar 

  4. Sparrow GEA, Rubens RD: Brain metastases from breast cancer: clinical course, prognosis, and influence on treatment.Clin Oncol 7:291–301, 1981.

    PubMed  CAS  Google Scholar 

  5. Boogerd W, Dalesio 0, Bais EM,et al: Response of brain metastases from breast cancer to systemic chemotherapy.Cancer 69:972–980, 1992.

    Article  PubMed  CAS  Google Scholar 

  6. Stewart JF, King RJ, Sexton SA,et al: Oestrogen receptors, site of metastatic disease, and survival in recurrent breast cancer.Eur J Cancer Clin Oncol 17:449–453, 1981.

    CAS  Google Scholar 

  7. Yamamoto N, Watanabe T, Katsumata N,et al: Construction and validation of a practical prognostic index for patients with metastatic breast cancer.J Clin Oncol 16:2401–2408, 1998.

    PubMed  CAS  Google Scholar 

  8. Harris M, Howell A, Chrissohou M,et al: A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast.Br J Cancer 50:23–30, 1984.

    PubMed  CAS  Google Scholar 

  9. Dixon AR, Ellis IO, Elston CW,et al: A comparison of the clinical metastatic patterns of invasive lobular and ductal carcinoma of the breast.Br J Cancer 63:634–635, 1991.

    PubMed  CAS  Google Scholar 

  10. Lemovec J, Bracko M: Metastatic pattern of infiltrating lobular carcinoma of the breast: An autopsy study.J Surg Oncol 48:28–33, 1991.

    Article  Google Scholar 

  11. Jain S, Fisher C, Smith P,et al: Patterns of metastatic breast cancer in relation to histologic type.Eur J Cancer 29A:2155–2157, 1993.

    Article  PubMed  CAS  Google Scholar 

  12. Gamel JW, Keeney AH: Metastasis to the eye and ocular adnexa. In: Donegan WL, Spratt JS eds, Cancer of the Breast, 4th ed, W.B. Saunders Company, pp712–716, 1995.

  13. Riley FG: Metastatic tumors of the eyelids.Am J Ophthalmol 69:259–264, 1970.

    PubMed  CAS  Google Scholar 

  14. Del Turco MR, Palli D, Cariddi A,et al: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial.JAMA 271:1593–1597, 1994.

    Article  Google Scholar 

  15. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial.JAMA 271:1587–1592, 1994.

    Article  Google Scholar 

  16. Fukutomi T: Breast carcinoma: counterpoint. In: Johnson SE, Virgo KS eds, Cancer Patient Follow-up, 1st ed, Mosby, St lous, pp315–319, 1997.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Higashi, H., Fukutomi, T., Watanabe, T. et al. Seven cases of breast cancer recurrence limited to the central nervous system without other visceral metastases. Breast Cancer 7, 153–156 (2000). https://doi.org/10.1007/BF02967448

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02967448

Key words

Navigation